MedPath

Soft Tissue Augmentation Around Dental Implant

Completed
Conditions
Gingival Atrophy
Registration Number
NCT06238427
Lead Sponsor
Mansoura University
Brief Summary

Patients were randomly distributed into two groups (G1 and G2), all patients were treated by a submerged dental implant protocol and free gingival graft (FGG) harvested from the palate as follows:

* Group 1 (G1), received the FGG two months before implant placement.

* Group 2 (G2), received the FGG at the time of second-stage surgery (i.e. at the time of healing abutment placement).

All periodontal and radiographic assessments were done by the same operator who was neither involved in the evaluation nor the distribution process. The operator did all the evaluation steps and was completely blinded to the treatment protocol.

Detailed Description

In this investigation, a randomized clinical trial was employed. The patient's randomization was completed by one of the department's senior residents, who was not involved in the trial and was unaware of any relevant treatment plan. A computer-generated randomization list used a randomization table to perform the randomization (SPSS v23.0). Patients were randomly distributed into two groups (G1 and G2), all patients were treated by a submerged dental implant protocol and FGG harvested from the palate. All patients received a thorough description of all procedures involved in the study. Signing a written consent was mandatory for being enrolled in the study. Complete medical and dental histories were recorded for all patients and complete clinical intraoral and extraoral examinations were done for all patients.

Selected patients were questioned about the cause and time of extractions, whether extractions were because of periodontal disease, dental decay or other causes. Previous experiences with dental procedures were also discussed. Intraoral photographs were taken to record the existing condition of teeth and mucosa before implant placement.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age: 21 years or older
  • Systemic Condition: Healthy
  • Keratinized Mucosa Width: Less than 2mm at the intended implant site
  • Bucco-lingual Bone Width: At least 5.5 mm in a single edentulous space
  • Mesio-distal Distance: At least 7 mm between adjacent teeth in a single edentulous space
  • Minimal Bone Height: Not less than 10 mm
  • Residual Alveolar Ridge: Healthy and well-formed, covered with firm mucosa
  • Periodontal Health: Absence of signs of periodontal bone loss or significant soft tissue .loss in teeth adjacent to the implant site
  • Inter-arch Space: Adequate, exceeding 7 mm
Exclusion Criteria
  • Cooperation: Uncooperative patients
  • Pregnancy: Individuals with known pregnancies
  • Parafunctional Habits: Abnormal parafunctional habits such as bruxism and clenching
  • Systemic Illnesses: Patients with systemic illnesses that could disrupt healing
  • Medication: Individuals receiving systemic corticosteroids or other drugs impacting .osseointegration or post-operative healing
  • Smoking: Smokers consuming more than 10 cigarettes per day

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Graft Shrinkage1 month, 3 months, 6 months, and 9 months

The decrease in the size of the graft at each follow-up time was compared to the baseline. size. It was presented in percentage

Keratinized Mucosa Width (KMW)Baseline, 1 month, 3 months, 6 months, and 9 months

Measurement Method: The assessment of KMW involved measuring from the alveolar ridge zenith to the muco-gingival junction (MGJ) using a calibrated periodontal probe.

Unit of Measure: Millimeters (mm)

Soft Tissue Thickness (STT)Baseline, 1 month, 3 months, 6 months, and 9 months

Measurement Method: STT was determined 1.5 mm apical to the soft tissue margin (STM) using a short anesthesia needle or endodontic micro-opener with a silicon stopper.

Unit of Measure: Millimeters (mm) Measurement Procedure: The needle was inserted perpendicular to the mucosal surface, through the soft tissues with light pressure until a hard surface was felt. The silicon stopper was placed in tight contact with the soft tissue surface, and the penetrated part was measured on an endodontic ruler. Measurements were rounded to the nearest half of a millimeter.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wafaa saleh

🇪🇬

Mansoura, Dakahlia, Egypt

© Copyright 2025. All Rights Reserved by MedPath